Exploiting Protein Conformational Change to Optimize Adenosine-Derived Inhibitors of HSP70 was written by Cheeseman, Matthew D.; Westwood, Isaac M.; Barbeau, Olivier; Rowlands, Martin; Dobson, Sarah; Jones, Alan M.; Jeganathan, Fiona; Burke, Rosemary; Kadi, Nadia; Workman, Paul; Collins, Ian; van Montfort, Rob L. M.; Jones, Keith. And the article was included in Journal of Medicinal Chemistry on May 26,2016.Recommanded Product: 550-33-4 The following contents are mentioned in the article:
HSP70 is a mol. chaperone and a key component of the heat-shock response. Because of its proposed importance in oncol., this protein has become a popular target for drug discovery, efforts which have as yet brought little success. This study demonstrates that adenosine-derived HSP70 inhibitors potentially bind to the protein with a novel mechanism of action, the stabilization by desolvation of an intramol. salt-bridge which induces a conformational change in the protein, leading to high affinity ligands. We also demonstrate that through the application of this mechanism, adenosine-derived HSP70 inhibitors can be optimized in a rational manner. This study involved multiple reactions and reactants, such as (2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(9H-purin-9-yl)tetrahydrofuran-3,4-diol (cas: 550-33-4Recommanded Product: 550-33-4).
(2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(9H-purin-9-yl)tetrahydrofuran-3,4-diol (cas: 550-33-4) belongs to tetrahydrofuran derivatives. THF (Tetrahydrofuran) is water-miscible and has a low viscosity making it a highly versatile solvent used in a variety of industries. Tetrahydrofuran can also be produced, or synthesised, via catalytic hydrogenation of furan. This process involves converting certain sugars into THF by digesting to furfural. An alternative to this method is the catalytic hydrogenation of furan with a nickel catalyst.Recommanded Product: 550-33-4
550-33-4;(2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(9H-purin-9-yl)tetrahydrofuran-3,4-diol;The future of 550-33-4;New trend of C10H12N4O4 ;function of 550-33-4